Podcasts about MPH

The Two Bobs episode 307 for Monday, March 2, 2026: What are The Bobs drinking? Rob enjoyed a Kentucky Bourbon Barrel Toasted Stout from Lexington. https://untp.beer/e65e9d5e8e Robert nursed a Cookie Exchange Milk Stout: Berry Jam Thumbprint from Great Lakes Brewing. https://untp.beer/2nKdq Follow us on Untapped at @RobFromTTB and @lowercaserobert or we'll give your preteen the keys to your car. If you typically use hotel coffee makers, you may stop after hearing this. This week's CRAZY NEWS recommends watching the State of the Union on mute while listening to Bad Bunny. A Kentucky man, covered in fur and blood, was arrested after being caught fucking a dead dear. https://local12.com/news/nation-world/allen-osborne-kentucky-man-covered-in-fur-arrested-after-allegedly-being-caught-having-sex-with-dead-deer-cincinnati-crime-criminal-activity-sexual-crimes-against-animal-charges-intercourse-corpse-abuse-allegations-investigation-911-call-law-enforcement Florida Woman® assaulted her boyfriend with pickles. https://www.thesmokinggun.com/buster/assault/pickle-assault-case-490782 A 12-year-old in North Carolina was pulled over while driving himself to school after missing the bus. https://nypost.com/2026/02/19/us-news/12-year-old-north-carolina-boy-pulled-over-for-driving-himself-to-school-after-missing-bus/ Florida Man® is being accused of driving 129 MPH to make it back from McDonald's in time. https://www.wtsp.com/article/news/local/nation-world/clearwater-super-speeder-arrest-mcdonalds/67-c477ec52-9dbf-48b9-965c-630888dc8ece A man in Indiana was mad that he had to finish chewing the food in his mouth before he could chew new food. https://theonion.com/man-annoyed-he-has-to-chew-current-food-before-he-can-chew-next-food/ Find us wherever you get your podcasts. Rate, review, and tell your equally twisted friends. Join us on all the social things: Follow us on Blue Sky Follow us on Twitter Check out our Instagram Find us on YouTube Follow Rob on Untappd Follow Robert on Untappd The Two Bobs Podcast is © The Two Bobs.  For more information, see our Who are The Two Bobs? page, or check our Contact page.  Words, views, and opinions are our own and do not represent those of our friends, family, or our employers unless otherwise noted.  Music for The Two Bobs was provided by JewelBeat (which doesn’t exist anymore but we still put it here because we like to do the right thing)

Fantasy Baseball Live – March 1, 2026Microsoft Teams:Segment 1 – Review Tim's LABR DraftFantasy Football Baseball Basketball and DFS | RealTime Fantasy SportsSegment 2 – News and Notes1.Zack Wheeler might not have much, if any, time, as he's being targeted for a debut on April 9th. He hasn't risen too much in ADP, likely as TOS has proven challenging to work through. He went in the early part of the eighth round in LABR. Thoughts on how to handle Wheeler this season?2.What did you think of Tatsuya Imai debut? He averaged 93.3 MPH with his fastball.3.I'm sure we will discuss Josh Hader in the next segment, but there is no timetable yet for him to start throwing. How are you handling Hader this season? He went in the 11th round in LABR, so people seem concerned.4.MLB.TV has changed – I'll explain.Segment 3 – Closer Report1.The Closer Report was relatively stable until the trade deadline and then became volatile in August. Looking at the board, do you see a stable closer board this season, or is it just too hard to predict?t?2.We will go through each team and discuss the closer situation.3.What are your five sleepers for saves this season?4.Do you have a couple of deep sleepers that you could recommend?

What does truly integrated care look like – and what role should dental hygienists play in it? As National Children's Dental Health Month comes to a close, host Matt Crespin sits down with two speakers from ADHA's first-ever Integrated Care Summit to explore how medical-dental integration is reshaping patient care. Nevada hygienist Jessica Woods shares real-world cases – from cardiologist referrals to coordinating airway care for her own daughter – that prove integration isn't just for public health settings. Pediatrician Dr. Connie Gundacker offers a medical perspective, revealing why most physicians receive little to no oral health training and how hygienists can bridge that gap. Together, they make a compelling case: dental hygienists are uniquely positioned to lead integration efforts, if the profession seizes the opportunity. Matt also covers ADHA award nominations, OPA legislative updates and upcoming events. Join these speakers and more at the Integrated Care Summit, May 15–17 in Broomfield, Colorado.Guests: Constance Gundacker, MD, MPH, FAAP, Section Chief of General and Community Pediatrics, Medical College of Wisconsin and Jessica L. Woods, MPH, RDH, FADHA, Chief Executive Officer, Executive RDHHost: Matt Crespin, MPH, RDH, FADHA

For many of us in the “sandwich generation” – those raising kids while caring for aging parents – preventive health can feel like one more impossible task on an already full plate. But prevention isn’t just about protecting your future; it’s about preserving your energy so you can show up for the people who need you right now. We spoke with Eduardo Sanchez, MD, MPH, FAHA, chief medical officer for prevention at the American Heart Association, about a practical framework for health and how sleep, stress, mental well-being, and social connection all play a role in heart health, stroke prevention, and even cognitive health. Taking care of yourself isn’t selfish – it’s preventive medicine that shapes your future. Additional resources:Life’s Essential 8MyLifeCheckYour Health Care Journey Credits Host: Neha Pathak, MD, FACP, DipABLM Producer/Editor: Lauren Summers Show Notes: Lauren Summers Guest: Eduardo Sanchez, MD, MPH, FAHA See omnystudio.com/listener for privacy information.

Pediatric Dentist and Entrepreneur Dr. Tyler Hanks joins host Dr. Joel Berg for a discussion on designing your own brand rooted in authenticity. Dr. Hanks talks about how he has found success leaning into his passions and personality in ways that put patients and parents at ease as soon as they enter his practice. He also delves into the social media side of his practice and the trial and error of finding unique and engaging ways to meet families where they are when they're looking for expert advice. Guest Bio: Dr. Tyler Hanks, DMD, MPH is a board-certified pediatric dentist and the founder of Happy Tooth Pediatric Dentistry in Millcreek, Utah. Born and raised in Sandy, Utah, Dr. Hanks has deep roots in the community and a genuine passion for helping children develop lifelong healthy smiles. Dr. Hanks began his dental journey after graduating from Brighton High School and serving a mission in Nicaragua for the Church of Jesus Christ of Latter-day Saints. He earned his Doctor of Dental Medicine (DMD) and a Master of Public Health (MPH) from the Arizona School of Dentistry & Oral Health, and completed specialized pediatric dental residency training at Children's Mercy Hospital in Kansas City. With over a decade of experience observing pediatric practices, Dr. Hanks believes that a child's first dental experiences have a lasting impact on their attitudes toward oral health. This philosophy inspired him to create Happy Tooth—an intentionally welcoming, fun, and kid-friendly environment designed to make dental visits enjoyable and comfortable for families. Dr. Hanks lives with his family in Utah and enjoys spending time with his four sons. Outside the office, he loves cheering on sports teams, playing board games, cruising around Millcreek on his OneWheel, and daydreaming about Lake Powell. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Lillian Erdahl, MD, FACS, is joined by Jessica Liu, MD, MS, MPH, from the Department of Surgery, Harbor UCLA Medical Center. They discuss Dr Liu's recent article, “Identifying Diagnostic Gaps and Mitigation Strategies for Older Adult Emergency General Surgery Patients: A Scoping Review,” in which the authors identified the current diagnostic issues, clinical tools, and clinician feedback strategies in the older adult emergency general surgery (EGS) setting. While challenges unique to older adults exist, variability in the use of tools to improve identification of older adult conditions in EGS and gaps in feedback to improve diagnosis remain.   Disclosure Information: Drs Erdahl and Liu have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Liu, Jessica K MD, MS, MPH; Peters, Xane D MD, MS; Remer, Sarah L MD; Beestrum, Molly MLIS; Cooper, Zara MD, FACS, MPH; Russell, Marcia M MD, FACS; Hall, Bruce L MD, FACS, PhD; Ko, Clifford Y MD, FACS, MSHS, MS. Identifying Diagnostic Gaps and Mitigation Strategies for Older Adult Emergency General Surgery Patients: A Scoping Review. Journal of the American College of Surgeons 241(5):p 904-916, November 2025. | DOI: 10.1097/XCS.0000000000001480   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord   Copyright © 2026 by the American College of Surgeons (ACS). All rights reserved.   The contents of these materials may be cited in academic publications but otherwise may not be reproduced, disseminated, or transmitted in any form by any means without the express written permission of ACS. These materials may not be resold nor used to create revenue-generating content by any entity other than the ACS without the express written permission of the ACS. The contents of these materials are strictly prohibited from being uploaded, shared, or incorporated in any third-party applications, platforms, software, or websites without prior written authorization from the ACS. This restriction explicitly includes, but is not limited to, the integration of ACS content into tools leveraging artificial intelligence (AI), machine learning, large language models, or generative AI technologies and infrastructures. 

How can Tai Chi be medicine? Sunny Pak, MD, MPH, shares simple movements that steady the mind, strengthen the body, and enhance qi flow. Series: "UCSF Honoring Origins of Mindfulness Series" [Health and Medicine] [Show ID: 41317]

Welcome to the world of Hexagonia 01. [HEXAGON] DJ Licious X Coldfire - Do As I Say02. CRi & Harry Hayes - Your Love03. Harry Hayes - I Did You Wrong04. Hitch & Warren - The Moment05. [THROWBACK TRACK] Zonderling - Tunnel Vision (Don Diablo Edit)06. KNWN - I Can't Live ft. Hutty07. John Summit - Lights Go Out (G-POL Remix)08. [HEXAGON RADIO CLASSIC] Olive - You're Not Alone09. [FUTURE] FAZE X & IQoniK - Wanna Be10. [DEMO OF THE WEEK] KO!MA X STAN ZO - 8A8Y11. Longstoryshort - Rockin The Drums ft. Pulsedriver & MC Hughie Babe12. [HΞXHIBITION] Fletcher Kerr - ENRGY13. Eats Everything - Make Some Noise14. MPH, Æ - Flex ItHaskell Guest Mix:15. [HEXAGON] Haskell - Magic Pills16. Haskell - Balonga17. Haskell - ID18. Haskell - Perfect Sound19. Haskell- Suave Suave20. Haskell & Silque - The Heat21. Haskell - ICE22. Haskell - Love Dealer23. Haskell - Psycho24. Haskell - The Power Of Speech25. Haskell- Lose Your Mind ft. David LeSal[CHILL TIME] Lane 8 & MYRNE - Adelie

Omari Richins, MPH of Public Health Careers podcast explores the deep connections between Black History Month and public health, emphasizing how historical struggles and initiatives within Black communities have shaped modern public health policies and practices. Omari highlights the contributions of the Black Panther Party and other historical figures in advocating for health equity, community health, and social justice, urging listeners to recognize and continue this legacy in their own work.

The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat. Many practices would benefit from any support that would give endocrinologists more capacity to focus where they really need to. Could advance practice providers, such as nurse practitioners and physicians assistants, be able to provide that support if they had a little more training?   The Endocrine Society and the American Association of Nurse Practitioners? (AANP) think so. Together they have developed a new program called Clinical Advantage: Endocrinology Certificate for Advanced Practice Providers. What does the certificate represent, how does the program work?   To help answer those questions and more host Aaron Lohr talks with two guests who helped develop the program: Sara R. MacLeod, DO, MPH, Assistant Professor of Medicine at University of Rochester; and Shannon K. Idzik, DNP, CRNP, ANP-BC, FAANP, FAAN, Professor and Associate Dean for the Doctor of Nursing Practice Program at University of Maryland School of Nursing.   Listen to learn how Clinical Advantage is working to address the shortage. Show notes are available at https://www.endocrine.org/podcast

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis sat down with guest Susana M. Campos, MD, MPH. Dr Campos is the clinical director and director of Educational Initiatives for the of the Division of Gynecologic Oncology at Dana-Farber Cancer Institute, and an institute physician and assistant professor of medicine at Harvard Medical School in Boston, Massachusetts. Drs Matulonis and Campos discussed the evolving landscape of newly diagnosed cervical cancer, from epidemiologic trends to emerging therapeutic strategies.According to 2026 estimates from the American Cancer Society, approximately 13,400 new cases of invasive cervical cancer will be diagnosed in the United States, with roughly 4200 deaths. Although incidence has declined over time due to human papillomavirus (HPV) vaccination and screening efforts, rates have plateaued, and the disease burden remains substantial, particularly among women aged 35 to 64 years. Dr Campos noted that approximately half of cases occur in women younger than 50 years of age, and about 20% are diagnosed in women older than 65 years of age.Dr Campos reviewed common presenting symptoms, including abnormal vaginal bleeding, intermenstrual or postmenopausal bleeding, abnormal discharge, pelvic pain, and, in advanced cases, urinary symptoms or leg swelling. She explained that diagnosis begins with pelvic examination and cervical cytology or HPV testing, followed by colposcopy and biopsy when indicated. Although cervical cancer remains one of the few malignancies that is clinically staged, imaging modalities, such as MRI, CT, and PET scans, are critical to accurately defining disease extent, they underscored. Moreover, the discussion highlighted transformative advances in locally advanced disease. The phase 3 KEYNOTE-A18 trial (NCT04221945) demonstrated improved progression-free and overall survival with the addition of pembrolizumab (Keytruda) to standard chemoradiation, establishing a new standard for high-risk patients, Campos stated. Similarly, the phase 3 INTERLACE trial (NCT01566240) showed that short-course induction chemotherapy with carboplatin and paclitaxel before chemoradiation improved long-term outcomes. Campos forecasted that ongoing studies, including the phase 3 NRG-GY037 trial (NCT07061977), may integrate these approaches and further refine optimal treatment sequencing.Lastly, Drs Matulonis and Campos highlighted the expanding therapeutic arsenal in the recurrent and metastatic setting. Campos noted how antibody-drug conjugates, such as tisotumab vedotin-tftv (Tivdak) and fam-trastuzumab deruxtecan-nxki (Enhertu), have demonstrated meaningful activity, particularly in biomarker-selected populations. Campos added that investigational strategies targeting TROP2, such as sacituzumab govitecan-hziy (Trodelvy), represent additional promising avenues.Despite these advances, both experts emphasized that prevention remains paramount. Widespread uptake of HPV vaccination, including the 9-valent vaccine, as well as adherence to routine cervical screening, are essential to reducing the long-term burden of this largely preventable disease.

Neurologic complications of hematologic disorders are frequently encountered in clinical practice and can involve both the central and peripheral nervous systems. Early recognition and appropriate management in collaboration with a hematologist are essential to reduce morbidity and mortality. In this episode, Kait Nevel, MD, speaks with Lauren Patrick, MD, and Mark Terrelonge, MD, MPH, authors of the article "Neurologic Complications of Hematologic Disorders" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Patrick is an assistant professor of neurology at the University of California, San Francisco, in San Francisco, California. Dr. Terrelonge is an associate professor of neurology at the University of California, San Francisco, in San Francisco, California. Additional Resources Read the article: Neurologic Complications of Hematologic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Full episode transcript available here Dr Nevel: Thick blood, thin blood. These are terms often used by patients and caregivers to describe some of the hematologic disorders that can lead to neurological diseases such as stroke. So, when should we consider a hematologic disorder as a potential cause for neurological conditions, such as stroke or neuropathy. Today I have the opportunity to interview Drs Lauren Patrick and Mark Terrelonge to learn more about neurologic complications of hematologic disorders in their recent article in Continuum. Dr Jones: This is Dr Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kate Nevel. Today I'm interviewing Drs Lauren Patrick and Mark Terrelonge about their article on neurologic complications of hematologic disorders. This article appears in the February 2026 Continuum issue on neurology of systemic disease. Welcome to the podcast, and please introduce yourself to the audience. Dr Patrick: Thank you for having us. We're both thrilled to be here. I'm Lauren Patrick, a vascular neurologist and assistant professor at the University of California, San Francisco, and program director for the Vascular Neurology Fellowship here. Dr Terrelonge: And I'm Mark Terrelonge, I'm an associate professor of neurology and neuromuscular medicine here at UCSF and one of the associate program directors for the adult neurology residency. Nice to meet you. Dr Nevel: Nice to meet you both. Really looking forward to getting into your article and learning more. So, to kind of kick us off, I always like to ask what do you think is the most important takeaway from your article for the practicing neurologist? And maybe since there are two of you and I suspect you covered slightly different aspects of this article, maybe you could give us two most important takeaways. Dr Patrick: Sure. I think the biggest takeaway is to keep hematologic disorders on the differential when evaluating patients with neurologic symptoms. Conditions like sickle cell disease, myeloproliferative neoplasms, or plasma cell dyscrasias and paraproteinemia can cause strokes or peripheral neuropathies, and many have specific and targetable treatments. The early recognition and collaboration with our hematology colleagues can truly change patient outcomes, whether that's by initiating cytoreductive therapy, managing thrombocytopenia, or optimizing antithrombotic therapy. Dr Nevel: Great. So, this is a really big and diverse topic. As always, I'm going to urge our listeners to read the article because there is a lot of really good stuff in your article that we just don't have time to get into during this interview today. But you cover a lot of different hematological disorders and how they can cause neurological complications. One of the major neurological complications of hematological disorders is cerebral vascular events. So, I'm hoping, Warren, that you can walk us through a little bit. When should we consider workup of potential hematologic disorder as a cause when we see a patient with ischemic stroke, because certainly not all patients with ischemic stroke should be getting a broad hematological disorder work up. So how can we kind of identify early on that there might be something else at play? Dr Patrick: Absolutely, great question. So, in many cases, the underlying hematologic disorder is already known, such as sickle cell disease or polycythemia vera. But sometimes stroke is the initial presentation or manifestation of the disease. So red flags can include young age, recurrent cryptogenic strokes or thrombosis, and unusual locations like the cerebral venous system. Laboratory clues such as unexplained erythrocytosis, thrombocytosis, thrombocytopenia, or hemolytic anemia should raise suspicion for an occult hematologic disorder. In the setting of acute illness, immune-mediated or heparin-induced thrombocytopenia or thrombotic microangiopathies should be suspected in patients that have hemorrhagic and or thrombotic complications, particularly when relevant lab disturbances are present. Acquired thrombophilia such as anti-phospholipid antibody syndrome should be considered in young patients with autoimmune disease, prior venous or arterial thrombotic complications, or pregnancy morbidity. Now, these are rare causes overall, but they're important to catch because the management can differ dramatically from our typical stroke care. Dr Nevel: Great. And what are some of the most common inherited or acquired thrombophilias and when should we be sending these labs? Dr Patrick: The hematologic causes really account for small minority of arterial strokes approximately one to two percent, but among those, sickle cell disease, anti-phospholipid antibody syndrome and the myeloproliferative neoplasms are the most common. Timing of testing is key. So, the genetic thrombophilia panels can be drawn at presentation, but lab values such as protein C, protein S, and antithrombin levels may be falsely low during acute thrombosis, so they're often repeated weeks later. Similarly, for anti-phospholipid antibody testing that should be done at presentation and when positive, confirmed at twelve weeks, since transient positivity can occur with affections or acute events. So, in patients that are already anticoagulated for anti-phospholipid antibody syndrome, testing becomes particularly tricky, especially with lupus anticoagulant assays. Some results need to be interpreted carefully or repeated when feasible. The main message is to collaborate early with our hematology colleagues to guide the timing and interpretation of these studies. Dr Nevel: Yeah, wonderful. Thank you. I'll ask some similar questions about neuropathy. So when should we consider an underlying hematologic disorder as being the cause for someone's neuropathy? Dr Terrelonge: So, luckily for a neurologist, then serum protein electrophoresis or an SPEP is already a part of the first pass evaluation for even the most common neuropathies we see, technically already considered every time we do an evaluation. However, we do know that most neuropathies progress very slowly and don't really lead to significant limitations in patient activities of daily living. And for those, the initial workup step, you may not need to do any additional search for any hematologic diseases after that first step. Within patients who start to have more unusual features with their neuropathy, including a rapid progression, early proximal weakness, significant and extremely painful neuropathies, significant ataxia, or new tremor or anything that's kind of outside of the garden variety neuropathy, then you should start to think about a hematologic cause. Additionally, if a patient already has a known hematologic malignancy or process before their neuropathy, there should be some form of assessment to see through exam or electrodiagnostically if the two are correlated. I do have to add one caveat, though, and that's just because someone has a hematologic malignancy or a paraprotein seen in their blood, their neuropathy and the neurologic syndrome don't necessarily have to be causally related. So, we have to do some additional testing to determine if the patient's presentation of the paraprotein are actually linked. Dr Nevel: Can you walk us through a little bit how we determine if they're associated or just coincidental? Dr Terrelonge: Yeah. So, for some of the proteins, there's a specific phenotype that will come with the specific protein. For example, an anti MAG proteinopathies or MAG standing for a myelin associated glycoprotein, it usually leads to a distal sensor and motor polyneuropathy where the most distal portions of nerves are affected. So, in that case, people might notice that they have numbness and weakness in their toes and their fingers, and it doesn't follow that typical length dependent pattern. So, in that case, if you have the anti mag neuropathy and the electrodiagnostic signature of an anti mag neuropathy along with the symptoms, you're more likely to think that the two are related then if not. Dr Nevel: Great. Thank you. And I was hoping you could speak a little bit more about amyloidosis just because I think that that's one that can be really tricky to diagnose. And I see patients, you know, have sometimes more drawn out evaluations or see multiple providers before a diagnosis is reached. So, can you speak a little bit more to how we diagnose amyloidosis in relationship to neuropathy or other neurological conditions and when we should push for more invasive testing like a nerve biopsy? Dr Terrelonge: So, amyloidosis certainly is a tricky diagnosis. I've been tricked by it and I think most of my neuromuscular colleagues have probably been tricked by it at least once. It's a hard diagnosis to make is it usually requires a pretty high index of suspicion, and also requires a tissue diagnosis to cinch. There're some patients who will come in with a prior history of amyloidosis and they're a little bit easier to figure out if the neuropathy is related. Maybe it's started in their heart or their kidney first and then you can just see if the type of amyloid they have usually deposits in nerve, and that may be enough. But if there's any diagnostic uncertainty, you could go forward with tissue biopsy. But it's patients in which the neuropathy is the first symptom that amyloidosis can be especially tricky to diagnose. It's a primarily light chain disease. So, if you do only an SPEP as a part of your initial neuropathy evaluation, you could miss it. But usually, the patients will have either a severely painful neuropathy, early autonomic dysfunction, or really prominent bilateral carpal tunnel syndrome. So, if they have any of those, usually we'll add in an amyloid workup as a part of that of the rest of the workup, which would include both light chain evaluations to see if there's any increase in Lambda or Kappa light chains and then also biopsy. Biopsy can be of the skin or fat pad first, which have reasonable sensitivity for picking up disease, but they're not necessarily a hundred percent. So if the suspicion remains high in those cases, a nerve biopsy should be considered. And the reason why this is important is that the chemotherapeutic agents that we have now can actually help arrest a lot of these diseases and stop further organ involvement. So, if you think about it, it is important to keep pushing and looking until you find it. Dr Nevel: Thank you so much for that. And a follow up question to that, once patients are started on appropriate therapy, the diagnosis is made, chemotherapy is started, what's the typical clinical course that you see in terms of their neuropathy? Do you ever see improvement or is it arrest of worsening? Dr Terrelonge: Usually for amyloid, there is an arrest of disease, but in some patients, they could have some improvement, not necessarily a dramatic improvement, but some patients could see some reversal of symptoms. That may not necessarily be because nerves injured nerves are regrowing, but because of reorganization of nerves to muscle, they could have some strength increases or at least less pain. Dr Nevel: Yeah, thank you. So, when should we involve a hematologist in aiding in the evaluation of patients we suspect may have an underlying hematological disorder? You guys really outlined very nicely in your article some of the laboratory workup or other workup like you just talked about with amyloidosis. But at what point in that workup should we reach out to our hematology colleagues? Dr Patrick: I would say almost always. So, these disorders are inherently multi-system and benefit from early co-management. In acute sickle cell stroke, for example, hematology helps direct emergent exchange transfusion. For myeloproliferative disorders they guide cyto reduction and long term antithrombotic strategy. And for antibody mediated or plasma cell disorders, hematology determines disease specific therapies. So, neurology may help with identifying the presentation, but the definitive management is almost always shared with our hematology colleagues. Dr Nevel: And as you both have mentioned that a lot of times in these cases, their hematologic disorder may be already known before they present with their neurological symptoms. So, I imagine obviously in those cases that a hematologist hopefully is already heavily involved in their care. What do you think is the most difficult aspect of identifying and diagnosing patients with neurologic illness as having an underlying hematological disorder? Dr Patrick: The hardest part is maintaining a high index of suspicion, especially since hematologic causes account for a very small minority of arterial strokes. Most strokes are from traditional vascular risk factors like you mentioned, or cardio embolism, so it's easy to stop diagnostic evaluation after standard studies have been performed. An example of a challenging case is a patient that's young, they've had recurrent cryptogenic stroke, and they could have antiphospholipid antibody syndrome, but it can be easy to miss if their antibody titers are borderline or if they're already anticoagulated, which would complicate retesting. So, it's about balancing the urge to over-test with recognizing the few cases where identifying A hematologic cause truly changes that management. Dr Terrelonge: And then on the neuropathy side, probably the hardest part is deciding what's causal and what's coincidence. Monoclonal gammopathy of unknown significance, or MGUS, is really common in older adults, so not every M-spike on an SPEP explains a neuropathy. And even sometimes there's times when the neurologic picture will develop a little bit faster than the hematologic one. So, it's hard to put the two together. Dr Nevel: Yeah. What's the most rewarding aspect of taking care of patients with complications from their hematologic disorders? Dr Patrick: It's deeply rewarding when a targeted diagnosis leads to a tangible improvement in that patient's care. For example, identifying A cryptogenic stroke is being due to myeloproliferative neoplasm or an inherited thrombophilia allows us to move from empiric treatment to possible disease specific strategy. It's really gratifying to give patients that clarity, to give them a diagnosis and in some cases prevent future events. Dr Terrelonge: Agreed. And even on the neuropathy side, almost all of the neuropathies that are hematologically related are treatable. So, it's so satisfying whenever you have a patient with say an anti-MAG neuropathy or Waldenström can start the patient on therapy, and you can see someone who's been having a progressive decline to stability and in those cases sometimes even significant recovery. Dr Nevel: Yeah, absolutely. Very rewarding when you can identify the problem and make it better. That's what it's all about. So, what are the future areas of research in this area? What do we still need to learn? Dr Patrick: There's still a lot to learn. I think we need better data on the safety of acute reperfusion therapy and antithrombotic agents, particularly in patients that are at dual risk for bleeding and thrombosis. Other examples, secondary prevention strategies and anti-phospholipid antibody syndrome. What's the best target INR? Do you add aspirin to warfarin or not? All of that is often left up to expert opinion. What's the best management for adults with sickle cell stroke? There are many open questions there. A lot of the protocols that we have in place for sickle cell patients that are adults as derived from pediatric literature and there's vast potential in terms of disease modifying therapies, especially in the fields of sickle cell disease and amyloidosis. And we'll need to reassess how those treatments may change neurologic outcomes. Dr Terrelonge: I think on the neuropathy side that having some form of new biomarkers to help us clearly know of the neuropathy and that hematologic illness are associated would be very helpful. On the treatment side, a lot of this is really being driven by the hematology space, but new therapies that treat hematologic plasma cell disorders, including some of the new BTK inhibitor, may be incorporated relatively soon into the algorithm for how we treat many of our patients. I'm excited to see what's to come from this. Dr Nevel: Wonderful. Thank you so much for sharing your knowledge with us today. I know I've certainly learned a lot by reading your article and through our discussion today. Highly encourage our listeners to read your wonderful article, which is a very thorough review of hematologic disorders and neurological complications. Again, today I've been interviewing Dr Lauren Patrick and Dr Mark Terrelonge on their article Neurologic Complications of Hematologic Disorders, which appears in the February 2026 Continuum issue on Neurology of Systemic Disease. Please be sure to check out Continuum Audio episodes from this and other issues. And as always, thank you so much to our listeners for joining today, and thank you so much to Lauren and Mark. Dr Terrelonge: Yeah, thank you so much for having us. Dr Patrick: Thank you so much for having us and for highlighting this topic. We hope the issue encourages clinicians to think broadly about hematologic causes of neurologic disease and to continue collaborating closely with our hematology colleagues. It's a complex but very fascinating intersection for both of our fields. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/AudioCME. Thank you for listening to Continuum Audio.

Interview with Cody Lendon Mullens, MD, MPH, MS, and Dana A. Telem, MD, MPH, authors of Contemporary Outcomes of Cholecystectomy. Hosted by Jamie Coleman, MD. Related Content: Contemporary Outcomes of Cholecystectomy From Safer Cholecystectomy to Smarter Bile Duct Management

Recently the federal government released new guidelines for alcohol and food. Marion Nestle discusses those new guidelines and her lifetime's work as a nutrition expert and nutrition policy advisor. Marion is a Paulette Goddard Professor of Nutrition, Food Studies, and Public Health, Emerita, at New York University in the department she chaired from 1988-2003 and from which she retired in September 2017. She has a PhD in molecular biology and an MPH in public health nutrition from the University of California. Marion is a past senior nutrition policy advisor in the Department of Health and Human Services and editor of the 1988 Surgeon General's Report on Nutrition and Health. She is the author, co-author, or co-editor of sixteen books, several of them prize-winning, most notably "Food Politics: How the Food Industry Influences Nutrition and Health" (2002); "Safe Food: The Politics of Food Safety" (2003); "What to Eat" (2006); and her new book, "What to Eat Now." Marion can be reached at Marion Nestle | NYU Steinhardt. Her books are available everywhere. The State of Wisconsin's Dose of Reality campaign is at Dose of Reality: Opioids in Wisconsin. More information about the federal response to the ongoing opiate crisis can be found at One Pill Can Kill. The views and opinions of the guests on this podcast are theirs and theirs alone and do not necessarily represent those of the host or Westwords Consulting. We're always interested in hearing from individuals or organizations who are working in substance use disorder treatment or prevention, mental health care and other spaces that lift up communities. This includes people living those experiences. If you or someone you know has a story to share or an interesting approach to care, contact us today! Follow us on Facebook, LinkedIn, and YouTube. Subscribe to Our Email List to get new episodes in your inbox every week!

Candice K. Silversides, MD, FACC, Editor-in-Chief of JACC: Advances, interviews authors Sarah Godfrey MD, MPH, FACC and Caroline L. Doherty DNP, AGACNP-BC, FACC about their paper, "Identifying Palliative Care Competencies for Cardiology Fellowship Training: A National Delphi Consensus Study" published in the February 2026 issue of the Journal.

Presented by Karly Hampshire, MD; Natasha Sood, MD, MPH; and Bhargavi Chekuri, MD (Moderator)STFM Conference on Medical Student Education Closing Session | Sunday, February 1, 2026Climate change is the greatest health threat of the 21st century, yet medical education has been slow to prepare future physicians for its wide-ranging impacts on health systems and patient care. In this session, we spotlight the power of student-led innovation in advancing climate and health education through two globally recognized initiatives: the Planetary Health Report Card (PHRC) and Climate Resources for Health Education (CRHE). Both began as grassroots projects by medical students who identified gaps in their training and took action to fill them. PHRC now benchmarks health professional schools internationally on planetary health curriculum, research, and operations, while CRHE has developed a growing library of open-access teaching materials to equip faculty with ready-to-use climate and health resources.Through a panel discussion with the co-founders of PHRC and CRHE, participants will hear first-hand stories of how these initiatives were built, scaled, and sustained as international collaborations. Panelists will reflect on their “aha” moments, early challenges, and lessons learned in fostering inter-institutional collaboration, leveraging mentorship, and bridging the gap between education and clinical practice. As both panelists now train as residents, they will also share how their perspectives on climate and health education have evolved with greater exposure to patient care and health systems.This session will equip educators, learners, and leaders with practical insights on cultivating an entrepreneurial mindset, leveraging collaboration, and supporting the next generation of change agents in climate and health education.Learning ObjectivesUpon completion of this session, participants should be able to:Describe how trainee-led initiatives have advanced climate and health integration in medical education worldwide.Identify strategies for fostering collaboration, mentorship, and sustainability in grassroots educational innovations.Apply lessons from student innovators to support the development of new climate and health education efforts at their own institutions. Copyright © Society of Teachers of Family Medicine, 2026Karly Hampshire, MDKarly Hampshire is an internal medicine resident at Columbia University pursuing a career at the intersection of medical education, climate change, and health. As a medical student at University of California San Francisco, Karly founded the Planetary Health Report Card Initiative, a student-led, metric-based initiative to evaluate and inspire planetary health engagement at health professional schools worldwide, now active in over 180 health professional schools in 10 disciplines in 21 countries. She was also awarded the Emerging Physician Leader Award from Health Care without Harm for her Interview without Harm Initiative, an advocacy, research, and educational campaign urging decisionmakers to prioritize sustainability and equity in evolving decisions about the future of medical training interviews post-COVID. She currently is in the inaugural cohort of the GME Certificate of Distinction in Climate Change, Sustainability and Health at Columbia University.Natasha Sood, MD, MPHNatasha Sood is a resident at the Brigham and Women's Hospital Department of Anesthesiology. She received her Bachelor of Science from the University of Michigan and her Master of Public Health from Columbia University in Environmental Health Science with a specialization in Climate Change and Health. While in medical school at Penn State College of Medicine, Natasha co-founded the national organization, Medical Students for a Sustainable Future (MS4SF), and w

Brian Lohnes, NHRA on Fox lead announcer, joins Joe Castello for a deep preview of the 75th season of NHRA Drag Racing. Lohnes will discuss NHRA testing in Gainesville including Shawn Langdon's massive 345 MPH run, the final episode of Chasing Speed on Vice TV, and the upcoming Amalie Oil NHRA Gatornationals. Elon Werner, host of Life's a Drag will join WFO Joe to discuss Drag Race Bracket Bonanza's top moments bracket. Elon and Joe will preview the WFO league on DRBB and get ready for next week's Gatornationals. 🚨 Don't miss out! Subscribe to WFO Radio for weekly NHRA updates, driver interviews, and exclusive motorsport content. Hit the bell 🔔 for notifications! MERCH: https://www.teepublic.com/stores/wfo-radio?ref_id=24678 PATREON: https://www.patreon.com/WFORadio APPLE: https://podcasts.apple.com/us/podcast/wfo-radio-podcast/id449870843?ls=1 SPOTIFY: https://open.spotify.com/show/0oo5mn0E3VmfhRCTHyLQIS

Today, we're diving into how to navigate your darkest moments and emerge from grief, trauma, and pain into a future filled with hope, resilience, and joy. Dr. Samantha Blake Harte is a physical therapist, choreographer, speaker, podcast host, author, and retreat leader dedicated to helping others find their way through life's toughest challenges. In her book, “Breaking The Circuit: How To Rewire Your Mind for Hope, Resilience and Joy in the Face of Trauma,” Dr. Harte shares her deeply personal journey—including her mother's mental illness and her own struggles with betrayal, loss, and addiction—and offers a transformative blueprint for overcoming adversity and reclaiming joy. Note: Trigger warning sensitive content discussed in this episode https://drsamanthaharte.com/ Additional Resources:

North Shore Nine recaps the Pirates' wild 16-7 win over the Red Sox in Fort Myers on February 24. Konnor Griffin stole the show with two monster home runs, including one off Ranger Suárez, capped by a 111 MPH, 440-foot blast that even “broke” Statcast for a bit. We also hit on the big day at the plate across the lineup, Jhostynxon “The Password” Garcia flashing tools (stolen base + outfield assist), and early looks at the arms (Carmen Mlodzinski, Thomas Harrington, Antwone Kelly, Khristian Curtis). Plus: our trip to Pirate City, what stood out from drills/live BP, and a reminder — NS9LIVE is Wednesday at 8 PM at The Cut Golf & Grill in Palmetto (come hang if you're in the area). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send a textThe salt can make you or break you, and Rick White has lived on both sides of that line. From towing a $500 high school Corvette to Bonneville and setting a 151 mph record to piloting the first single-engine car beyond 400 mph, Rick's journey blends fearless engineering, family grit, and relentless problem-solving. Growing up at Nolan White's elbow and rooted in land speed racing, He watched his father enter the 200 MPH Club in 1963, he learned how to build speed from wood, steel, and stubborn ideas. We dig into the turning points that define land speed racing. Rick explains why he and Nolan built a rare four-wheel-drive streamliner in 1980 to fight traction loss, how blown fuel became their language, and what it took to sort a one-off machine aimed squarely at 400 mph. He breaks down the differences between SCTA and FIA records, why two-way runs collided with today's shorter, rougher salt, and the day parachute failure on a return run took his father's life. The conversation is raw, clear-eyed, and focused on what changed and what still drives him to innovate safely on the Bonneville Salt Flats. Then we go under the hood of Rick and his son Brad's current project: a competition coupe built around a tiny Honda 600 body to punch the smallest hole in the air. With a 540-cubic-inch blown-fuel big block, carefully set wheelbase, and a hand-formed aluminum nose, the car is aimed at a 305 MPH class record and a blue hat. Rick shares the fix that unlocked new pace—proper tank venting for a bigger fuel pump—and how a 257 mph El Mirage record proved the direction. His years in nostalgia top fuel, including March Meet and Hot Rod Reunion wins, and how the salt taught him how to be a better drag racer. If you love Bonneville history, four-wheel-drive streamliners, FIA records, and the hard math of traction, drag, and fuel delivery, this story hits all the marks. Tap play to hear a family legacy carried forward with craft, courage, and an unwavering eye on the next mile marker. If this conversation moved you, subscribe, share it with a friend who loves fast cars, and leave a quick review—your support helps more speed fans find the show.Support the show

Flint, Michigan was once known as one of America's most prosperous industrial cities. Decades of deindustrialization and a water crisis changed that, but crisis isn't the whole story. Laura Keen of GiveDirectly joins the podcast to explore the resilience behind the popular headlines, the gaps in America's safety net, and what the expanded Child Tax Credit revealed about child poverty. All of it set the stage for Rx Kids — one of the most ambitious social programs in the country.References for Our Discussion◼️The US town that pays every pregnant woman $1,500: ‘We're not OK with our babies being born into poverty' ◼️Direct Unconditional Cash Transfers Boost Well-Being for Mothers and Babies ◼️Perinatal Cash Transfers and Birth Outcomes: A Population-Based, Quasi-Experimental Study of the Rx Kids Unconditional Cash Prescription During Pregnancy and Infancy ◼️Hardship and Hope: The Relationship Between Unconditional Prenatal and Infant Cash Transfers, Economic Stability, and Maternal Mental Health and Well-Being◼️To End Extreme Poverty, Give Cash — Not Advice | Rory Stewart | TED◼️New research: Cash for pregnant moms in Flint led to healthier births and millions in healthcare savings Guest◼️Laura Keen, U.S. Program Director, GiveDirectlyHost◼️Gordon Thane, BMSc, MPH, PMP®Producer◼️Gordon Thane, BMSc, MPH, PMP®◼️Abhinya GulasingamProduction Notes◼️ Music from Johnny Harris x Tom Fox: The Music RoomLeave Us Some FeedbackIf you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people. You can also interact directly with the podcast episodes on Spotify using the new “comment” feature! We'd love to hear what you think.Send us a Text Message to let us know what you think.

A mom who went missing 24 years ago was found alive and well, she just didn't want to go back home...a man got busted for stealing a 13-thousand-dollar golf cart...and a man with a backpack FULL of drugs was busted after driving a 105 MPH!

This DermSurgery Digest bonus content aptly named “At the Microscope” shares the latest research and techniques in dermatopathology. In this episode, contributors review Endocrine Mucin ProducingSweat Gland Carcinoma (EMPSGC). Contributors to this podcast include Naomi Lawrence, MD, Dermatologic Surgery Digital Content Editor; Ashley Elsensohn, MD, MPH, DermSurgery Digest at the Microscope co-host; Christine Ahn, MD; Jeff Gardner, MD; Marina K. Ibraheim, MD; and Michael P. Lee, MD. Articles featured in this episode include:  ·        “TRPS1 Expression in Endocrine Mucin-Producing Sweat Gland Carcinoma: Diagnostic Utility and Pitfalls” The American Journal of Dermatopathology·        “Utility of Insulinoma-Associated Protein 1 (INSM1) and Mucin 2 (MUC2) Immunohistochemistry in the Distinction of Endocrine Mucin-Producing Sweat Gland Carcinoma From Morphologic Mimics” The American Journal of Dermatopathology·        “Endocrine Mucin-Producing Sweat Gland Carcinoma: Emerging Evidence of Multicentric Cutaneous Origin and Occasional Concurrence With Analogous Breast Tumors” The American Journal of Dermatopathology·        “An Update on Endocrine Mucin-producing Sweat Gland Carcinoma” The American Journal of Surgical Pathology  Your feedback is encouraged. Please contact communicationstaff@asds.net.

This week we're excited to revisit some of the best interviews from this podcast's +360-episode archive about making transformative, life- or career-changing transition decisions. This “Best of the Faculty Factory” compilation episode features clips from three important episodes in the Faculty Factory archive. (If you're interested in hearing the full conversations, you can find the original episodes below). Appearing in order are the episodes that were clipped for this podcast: A Faculty Factory Interview with Peter Densen, MD: https://youtu.be/3IikA7FUa_A Considerations for Life After Full-Time Employment in Academic Medicine with Lawrence Appel, MD, MPH: https://youtu.be/kFPjXOq8yfY Key Factors to Consider When Shifting to a New Leadership Role with Maria Oliva-Hemker, MD: https://youtu.be/OBkibXyO7tQ If this episode interests you, you can also revisit our episode called, “Making a Decision to Transition in Academic Medicine”:  https://youtu.be/hqr8yDx8rZk Which featured snippets from the following episodes: Navigating a “Decision to Transition” in Academic Medicine with Jochen Reiser, MD, PhD: https://youtu.be/hqr8yDx8rZk Navigating a Transition from Academia to Industry and Back with Ludy Shih, MD, MMSc: https://youtu.be/9nH8QexHJ5M Adaptability for Success at Any Stage of Your Academic Medicine Career with Janet Bickel, MA: https://youtu.be/5Nxkv-2yHc0

NEED HELP FOR AN EATING DISORDER? Call: 888-364-5977 or head to: https://emilyprogram.com/begin-recovery/ Host Lindsey Elizabeth Cortes interviews Dr. Jillian Lampert (Vice President of Strategy and Public Affairs at The Emily Program), who explains eating disorders as mental health diagnoses that disrupt a person's relationship with food and negatively impact life, and outlines diagnoses including anorexia nervosa (including that it can occur without visible underweight), bulimia nervosa, binge eating disorder, ARFID, and OSFED; she notes orthorexia is not currently a DSM diagnosis. They discuss why athletes are at higher risk (temperament traits like persistence, rule-focus, and high standards combined with sport pressures), warning signs such as secrecy, defensiveness, and constant preoccupation with food, and serious health consequences including RED-S impacts, cardiac risk (especially with purging and electrolyte disruption), GI issues, bone and endocrine effects, and dental damage. Dr. Lampert describes The Emily Program's full continuum of care (inpatient through outpatient, including virtual options), emphasizes individualized treatment for athletes (including decisions about training/competition), and shares Jessie Diggins' public story of treatment, recovery, relapse, and ongoing support; the episode closes with encouragement to seek help by calling or requesting contact through emilyprogram.com. Dr. Jillian Lampert, PhD, MPH, RD, LD, FAED, is the Vice President of Strategy and Public Affairs for The Emily Program, a national eating disorder treatment company. She completed her doctorate degree in Nutrition and Epidemiology and Master of Public Health degree in Public Health Nutrition at the University of Minnesota. She earned a Master of Science degree in Nutrition at the University of Vermont and completed her dietetic internship at the University of Minnesota Hospital and Clinics. She has an expansive range of policy, clinical, research, education, teaching, and program development experience in the area of eating disorders. Episode Highlights: 01:22 Sponsor Break: WaveBye for Period Pain & Cycle Support 03:00 Eating Disorder Help Resources (NEDA + Emily Program) 04:00 Meet Dr. Jillian Lampert + Why Awareness Week Matters 06:26 Eating Disorders 101: What They Are (and Aren't) 08:31 Types of Eating Disorders: Anorexia, Bulimia, Binge Eating, ARFID, OSFED 12:21 Where Orthorexia Fits + When “Healthy Eating” Becomes Harmful 15:25 Why Athletes Are Higher Risk: Temperament, Perfectionism & Pressure 17:25 Crossing the Line: Red Flags Like Secrecy, Defensiveness & Isolation 21:21 The “Iceberg” of ED Thoughts + How Much You Think About Food 25:02 Sponsor Break: RED-S Quiz + Recovery Membership & Coaching 27:34 Physical Consequences: RED-S, Heart Risk, Electrolytes & GI Damage 34:43 Why you should still talk to a doctor (even if they're not ED-trained) 35:24 From consequences to recovery: the real goal is feeling good again 36:02 Inside The Emily Program: levels of care from inpatient to outpatient 37:59 What makes The Emily Program different: all levels, nationwide, long-term support 40:32 Athletes & recovery goals: using your drive without expecting a quick fix 41:54 Jessie Diggins' story: treatment, relapse, and staying on the team 43:00 Can you keep training in treatment? How athlete care is individualized now 51:45 Recovery is possible: skills that last, hope after relapse, and being your best self 55:28 How to get help today: website, phone call, and don't wait 59:03 Final takeaway + where to find resources and support Resources and Links: For more information about the show, head to work with Lindsey on improving your nutrition, head to: http://www.lindseycortes.com/ Join REDS Recovery Membership: http://www.lindseycortes.com/reds WaveBye Supplements – Menstrual cycle support code LindseyCortes for 15% off: http://wavebye.co Previnex Supplements – Joint Health Plus, Muscle Health Plus, plant-based protein, probiotics, and more; code CORTES15 for 15% off: previnex.com Female Athlete Nutrition Podcast Archive & Search Tool – Search by sport, condition, or topic: lindseycortes.com/podcast Female Athlete Nutrition Community – YouTube, Instagram @‌femaleathletenutrition, and private Facebook group Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Omari Richins, MPH of Public Health Careers podcast talks with Jennifer Kuo, MPH, CHES.In this episode, Jennifer Kuo shares her journey at the intersection of arts and public health - and why creative approaches are essential to building healthier communities. She breaks down social prescribing and its growing role in the U.S. healthcare system, highlighting how arts and culture support well-being, connection, and healing.Jennifer discusses her path from the arts into public health, her academic and professional experiences, and what her day-to-day work looks like in the field of creative health. The conversation explores community engagement, social determinants of health, and how to design and evaluate inclusive, arts-based health initiatives. She also reflects on personal growth, leadership, and offers practical advice for aspiring public health professionals looking to find their niche in this evolving space.Link to shownotes

Acompáñanos en esta emotiva conversación de cierre y celebración de una etapa inolvidable en Microbios. Después de tres años al frente de Microbios, el Dr. Máximo Brito —Profesor de Medicina en la Universidad de Illinois en Chicago y Jefe de Enfermedades Infecciosas en el Jesse Brown VA Hospital— se despide como anfitrión del podcast. En este episodio especial, conversamos con el Dr. Brito sobre su trayectoria como infectólogo, científico y comunicador, recordando sus momentos más memorables frente al micrófono. Además, comparte reflexiones sobre lo aprendido, anécdotas y su visión para el futuro del programa. La conversación también marca el inicio de una nueva etapa: el Dr. Brito le pasa la antorcha a la Dra. Brendaliz Santiago- Narvaez, quien asumirá el rol de anfitriona y continuará el legado de Microbios. Invitado: Maximo O. Brito, MD, MPH, FACP, FIDSA Temas destacados: El comienzo: ¿Cómo surgió la oportunidad de liderar el podcast? Mirando hacia atrás: su episodio y momento favorito como anfitrión. Los Microbios- Cuales son sus microbios favoritos? Detrás del micrófono: lo que no se ve del trabajo de producir Microbios. Pasando la antorcha: consejos para la nueva conducción. Mirando hacia adelante: la evolución del podcast bajo nuevo liderazgo Palabras finales: el mensaje de despedida del Dr. Brito a la audiencia.

SHOW NOTES: The winter Olympics had a boring opening ceremony except for Andrea Bocelli. Some of the events seem duplicative, especially figure skating and skiing. Some seem like efforts to avoid death or injury, and not just competing—skeleton, luge, giant slalom, ski jumping, distance skiing. Skiing in ruts is rather boring, and then the women collapsing over the finishing line and gasping for air is frightening. The giant slalom hits about 85 MPH. Luge and skeleton runs are between 80 and 100 MPH. On the ice, men are tossing women around who have knives attached to their feet. The French judge in figure skating obviously downgraded the American and inflated the French scores so that the latter pairs won. That judge has been known to have done this throughout the last year. Now onto curling, which is a game played with stones and brooms, has suffered cheating accusations for the Canadians “double touching” the stone on launch. After a profane, long outburst by the accused, slow reply showed he, indeed, did commit the infraction. In a manner of speaking he “gave them the finger” before tongue lashing them with obscenities. So much for the Olympic spirit. (And for Canadians being nice people.) At the 2026 Winter Olympics in Milan-Cortina, Canadian curlers Marc Kennedy and Rachel Homan were accused of "double-touching" (illegally touching a stone after its initial release) in separate matches. Sweden's Oskar Eriksson initiated the allegation against Kennedy on Feb. 13, while officials flagged Homan on Feb. 14. Curling is basically the same as shuffleboard, which older people play in retirement villages, or bocce which specifically older Italian people play on dirt. Then there's the cousin, English Lawn Bowls, which I've never been able to finish watching without falling asleep. Johnny Weir, the former Olympic figure skater and NBC commentator, is renowned for his highly, flamboyant, and gender-neutral fashion choices while broadcasting, often featuring makeup, jewelry, and avant-garde, designer clothing. He and Sarah Lapinsky are worth the time spent watching people jump around on ice. Yes, it is true that the Olympic Village at the 2026 Milano Cortina Winter Games ran out of free condoms within the first three days, according to reports in La Stampa and The Guardian. Approximately 10,000 contraceptives for about 2,900 athletes were depleted quickly, prompting emergency restocking due to higher-than-expected demand. Now THAT'S the competitive spirit!

Join Digital Education Committee Vice-Chair and podcast host Tina Baykaner, MD, MPH, along with this week's guest contributors, Jackson J. Liang, DO and Edward P. Gerstenfeld, MD, MS, FHRS for this week's episode. This study evaluates the relationship between hospital ventricular tachycardia (VT) ablation volume and post-procedural complications, examining whether institutional procedural experience influences patient outcomes. The authors analyze complication rates across centers with varying VT ablation volumes to assess potential volume–outcome associations. Findings from this work provide important insights into procedural risk, quality metrics, and the potential impact of case volume on VT ablation safety.    Learning Objectives Describe the relationship between hospital VT ablation procedural volume and post-procedural complication rates. Identify patient, procedural, and institutional factors that may contribute to complications following ventricular tachycardia ablation. Discuss how volume–outcome findings can inform quality improvement initiatives, referral patterns, and procedural planning for VT ablation programs.    Article Authors Agam Bansal, Anirudh Nandan, Jakub Sroubek, Justin Lee, Koji Higuchi, Ayman Hussein, Shady Nakhla, Mina Chung, Niraj Varma, Walid Saliba, Mandeep Bhargava, Tyler Taigen, Mohamed Kanj, Oussama Wazni, and Pasquale Santangeli Podcast Contributors Tina Baykaner, MD, MPH Jackson J. Liang, DO Edward P. Gerstenfeld, MD, MS, FHRS   All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): T. Baykaner•Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbot Medical, Boston Scientific •Research: NIH   E. Gerstenfeld •Speaking/Teaching/Consulting: Medtronic, Adiago Medical, Biosense Webster, Inc., Abbott, Boston Scientific, Abbott Medical, Varian Medical Systems •Research: Boston Scientific, Abbott Medical •Board Membership: American College of Cardiology Foundation   J. Liang •Speaking/Teaching/Consulting: Biotronik, Abbott, Bionsense Webster, Inc.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

In this episode of ACEP Nowcast, host Amy Faith Ho, MD, MPH, FACEP, talks with emergency medicine leaders about the state of pediatric disaster readiness in EDs and the role of observation units in disaster response. More links: Read more on ACEPNow.com. Revisit ACEP Nowcast podcast episodes.  View job opportunities at emCareers.

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

We recently covered an SMFM abstract that was presented at the annual Pregnancy Meeting held in early February 2026. The authors were from my Alma Mater, UT Southwestern/Parkland Hospital. This was a well-done study comparing 162 milligrams aspirin to 81 milligrams of aspirin. The results were very encouraging! However, aspirin definitely has an awkward acumen. It would be wonderful if ALL the data just leaned in the same direction... but it doesn't! Enter our podcast family member, and my friend Alex. Alex sent me an incredible and insightful message which was a rebuttal to my Southwestern colleagues' findings. In this episode you'll hear Alex's rebuttal and clinical conundrum, and we will explain why these two seemingly paradoxical findings makes sense. Listen in for details.1. Khander, Amrin MD; Thomas, Charlene MS; Matthews, Kathy MD; Christos, Paul DrPH; Alcus, Claire BA; Alam, Tanvir BS; Bush, Leah BA; Deshmukh, Diksha BA; Chasen, Stephen T. MD; Riley, Laura E. MD; Skupski, Daniel W. MD; August, Phyllis MD, MPH; Malha, Line MD, MS. Comparison of 162 mg and 81 mg Aspirin for Prevention of Preeclampsia: A Randomized Controlled Trial. Obstetrics & Gynecology 147(1):p 87-96, January 2026. | DOI: 10.1097/AOG.0000000000006100

Gary & Ryan discuss the Yankees seeing Carlos Lagrange hit 102.6 MPH on the radar gun, Aaron Judge's "brutal" comments about the offseason's slow start, the outfield logjam, and MORE! Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this bonus episode, Sural Shah, MD, MPH, FAAP, discusses the impact of immigration enforcement on children. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, ask about how pediatricians can support families affected by U.S. Immigration and Customs Enforcement (ICE) and U.S. Customs and Border Protection (CBP) raids as well as the conditions of detention centers. For resources go to aap.org/podcast.

Dr. Nancy O'Hara, pediatrician and leading expert in PANS and PANDAS, joins me to unpack why some children experience sudden, dramatic changes in behavior, anxiety, OCD, tics, sleep, or emotional regulation following illness. For many families, these symptoms appear almost overnight and are often misdiagnosed as "just anxiety," behavioral issues, or psychiatric disorders, leaving parents confused, dismissed, and unsure how to help their child.   Together we explore:   - What PANS and PANDAS are, and how infections like strep, viruses, or tick-borne illness can trigger sudden neuropsychiatric symptoms in children. - What to assess to help you determine if your child has a generalized anxiety disorder or if it may be PANS/PANDAS that is the root cause of their symptoms. - Why PANS/PANDAS is often missed or misunderstood in both medical and mental health settings. - The three-pronged approach to treatment: Addressing the trigger, the immune system, and the child's emotional and behavioral symptoms. - How therapy, both for parents and children, can support recovery, even when symptoms have a medical origin. - Understanding that there is real hope for healing and that it's never too late to identify and address PANS or PANDAS.   This episode is designed to help parents and clinicians feel more informed, less alone, and more confident in recognizing when a child's behavior may be signaling something deeper. PANS and PANDAS are real, treatable conditions that deserve compassionate, comprehensive care.     LEARN MORE ABOUT MY GUEST:

Before he ever wore the uniform, Rolan Smith lived a life of chaos, brotherhood, and near-death experiences that most people wouldn't survive. In this Urban Valor episode, Rolan shares what really led him to enlist in the United States Marine Corps — and how an 85 MPH crash in the middle of the desert nearly ended that path before it began.Raised in Amarillo, Texas, Rolan was the definition of a wild kid. Sports, trouble, loyalty — and a brotherhood with his best friend Price that would take them from Friday night lights to fire teams. This is the story of what happens before the war… when life itself is already throwing punches.

A lot of women are stuck in a cycle of eating less, pushing harder, and starting over every Monday, only to feel more frustrated each time. The surprising part is that this isn't a lack of discipline, but a predictable outcome of years of under-eating and following advice that was never built for women's physiology.We dive deeper into this in the Broads podcast with Finley. We talk about why intermittent fasting often backfires for women, how sugar cravings are usually a fueling issue, what chronic under-eating does to your metabolism, and what sustainable nutrition actually looks like without diet culture noise.Finley Amato Funsten is a nutrition and strength coach, the founder of Unfuck Your Diet, and the owner of MADabolic Charlotte. Her work focuses on evidence-based nutrition, behavior change, and sustainable training practices.What's Discussed:(05:53) Diet Coke, aspartame safety, and why fear-based nutrition science still sticks(07:12) Why intermittent fasting often backfires for active women hormonally(09:04) How hunger hormones adapt when breakfast is skipped for years(11:04) Why named diets fail women by ignoring physiology and skill building(14:32) Skinny culture's return and how wellness marketing keeps women shrinking(19:20) Sugar cravings explained through protein and fiber deficiencies(24:39) Why detoxes and cleanses don't work the way people think(32:03) Chronic under eating signs including low energy, poor recovery, and cycle disruptionCheck out more from Broads:Website: www.broads.appInstagram: @broads.podcast @broads.appCheck out more from Tara LaFerrara:Website: http://taralaferrara.com  Instagram: @taralaferraraYoutube: https://youtube.com/@TaraLaferraraCheck out more from Finley Amato Funsten:Website: https://unfuckyourdiet.coInstagram: @unfuckyourdiet Check out some of Finley's favorite accounts for nutrition, fitness, and real talk:Tara LaFerrara: https://instagram.com/taralaferraraSheridan Skye, MSc: http://instagram.com/sheridanskyefitBeth Wilkas Feraco: http://instagram.com/bethferacofitnessAmanda Howell, MPH: http://instagram.com/amandahowellhealthJessica Knurick, PhD: http://instagram.com/drjessicaknurickDr. Stacy T. Sims: http://instagram.com/drstacysimsKate Lyman, MPH: http://instagram.com/klnutritionJordan Syatt: http://instagram.com/syattfitnessLayne Norton, PhD: https://www.instagram.com/biolayne

Send a textTim Seward built a 65 MPH electric moped in his garage to one-up his buddies. People wouldn't stop asking where to buy it. So he started Onyx Motors, raised almost a million bucks on Indiegogo in 3 hours… then sold the company for $1. When his successor died unexpectedly, Tim came back to rebuild from scratch. This is that story.The RCR 80V is a 91-volt electric motorbike that hits 65–75 MPH, goes 130 miles on a charge, runs Apple CarPlay, and costs about 75 cents to charge at home. It's built on a metal tube frame with swappable aluminum panels — designed from day one to be customized, modded, and made your own. Think less iPhone, more Lego kit.Tim breaks down the moped gang culture that started it all, why Americans are 20 years behind the rest of the world on two-wheeled transport, what he learned designing scooters at Bird, and why Gen Z might never buy a car.CHAPTERS0:00 – Cold Open0:00 – Intro: Who is Tim Seward?0:01 – Why Build Something That Lasts?0:03 – Moped Army & Moped Mondays0:05 – Moped Culture: US vs. the World0:07 – The Scooter Armageddon (Bird & South by Southwest)0:09 – Working at Bird & the Wheelchair-Accessible Vehicle0:11 – Red Lights & "It's Not For Sale"0:13 – The Indiegogo Campaign ($920K in Hours)0:15 – Selling Onyx for $10:18 – Losing James & Resurrecting the Brand0:21 – Starting a Company Twice0:22 – The RCR 80V: Size, Speed & Power0:25 – Regulations & Licensing0:26 – Metal vs. Plastic: Design Philosophy0:28 – Built to Customize (Not Lock Down)0:31 – CarPlay, Navigation & Built-In Tech0:33 – Mounting Points, Mods & Steady Garage0:36 – Swappable Panels & Custom Builds0:40 – Favorite Mods: Back to the Future Build0:43 – The $245B Electric Vehicle Market0:46 – Gen Z Doesn't Want Cars0:49 – Park It on the Sidewalk (or Your Desk)0:52 – Speed Modes & Motorcycle Registration0:54 – What's Next for Onyx Motors0:56 – Where to Buy + OutroLINKSOnyx Motors → https://onyxmotors.comOnyx on Instagram → https://instagram.com/onyxmotorsSteady Garage (aftermarket accessories) → https://steadygarage.comOnyx Garage (custom builds gallery) → https://onyxmotors.com/pages/garageClick Here to Subscribe: FUTR.tv focuses on startups, innovation, culture and the business of emerging tech with weekly podcasts talking with Industry leaders and deep thinkers.Occasionally we share links to products we use. As an Amazon Associate we earn from qualifying purchases on Amazon.

In this podcast, experts Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH; Ruth Carrico, PhD, DNP, FNP-C, FAAN; and Dalilah Restrepo, MD, discuss improving shingles vaccine uptake. Topics covered include: The Burden of ShinglesCare Coordination Between Primary and Specialty CarePromoting Shingles Vaccine Series CompletionAddressing Disparities in Shingles Vaccine Access and Uptake Presenters:Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPHAssociate Professor of Clinical PharmacyUniversity of California, San DiegoDepartment of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical SciencesDivision of the Black Diaspora and African American StudiesLa Jolla, CaliforniaRuth Carrico, PhD, DNP, FNP-C, FAANSenior PartnerCarrico & Ramirez PLLCProfessor, AdjunctDivision of Infectious DiseasesUniversity of Louisville School of MedicineLouisville, KentuckyDalilah Restrepo, MDInfectious Diseases SpecialistUniversity of California, IrvineLos Alamitos HospitalOrange County, California Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join us as we review and appraise recent practice-changing articles on oral semaglutide for obesity, fish oil in ESRD, IV iron during infection, the new US Dietary Guidelines, & anticoagulation after ablation in AFib. Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), Josh Gilman, & Matt Watto (@doctorwatto).Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMECredits Written and Hosted by: Rahul Ganatra MD, MPH; Paul Williams, MD, FACP, Joshua Gilman, MD, & Matthew Watto MD, FACP Cover Art: Rahul Ganatra, MD MPH Reviewer: Emi Okamoto, MD Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer Oral Semaglutide for obesity Fish Oil for CV risk reduction in hemodialysis patients IV Iron for iron deficiency anemia during infection New USA Dietary Guidelines Anticoagulation after catheter ablation for AF Outro Sponsor: FIGSCheck out the limited-edition Team USA collection, and get 15 percent off your first order at Wearfigs.com with code FIGSRX. Sponsor: Continuing Education CompanyVisit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.  Sponsor: GustoTry Gusto today at gusto.com/CURB, and get three months free when you run your first payroll.Sponsor: MDProgress For our listeners, enjoy your first month free at mdprogress.ca/promo/curbsiders

Join the Behind the Knife Surgical Oncology Team as we discuss the PRADO and NADINA randomized control trials regarding neoadjuvant therapy in Stage III melanoma with macroscopic nodal disease!Hosts:Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center.Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles.Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson.Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath.Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center.Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives:-       Evaluate the role of Completion Lymph Node Dissection (CLND) in patients with positive sentinel lymph nodes, specifically citing the lack of melanoma-specific survival benefit vs. the improvement in regional disease control demonstrated in the MSLT-II trial.-       Determine the appropriate surgical excision margins for primary cutaneous melanoma, comparing the outcomes of 1 cm versus 2 cm margins as analyzed in the MINT trial (Lancet 2019).-       Analyze the impact of adjuvant systemic therapy (Anti-PD1/Immunotherapy) on recurrence-free survival in patients with resected high-risk Stage III melanoma.References:Reijers, I.L.M., Menzies, A.M., van Akkooi, A.C.J. et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med 28, 1178–1188 (2022). https://doi.org/10.1038/s41591-022-01851-xChristian U. Blank et al. Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. J Clin Oncol 42, LBA2-LBA2(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA2*Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of the Neurocritical Care Society Podcast Hot Topics series, host Richard Choi, DO, FNCS, speaks with Wendy Ziai, MD, MPH, professor of neurology and critical care medicine at Johns Hopkins University, about the article The Association Between Hourly Systolic Blood Pressure Variability and Outcomes in Patients With Intracerebral Hemorrhage Is Time-Dependent: A Post Hoc Analysis of the ATACH-2 Trial, recently published in Neurocritical Care. Their discussion explores why blood pressure variability — not just absolute blood pressure targets — may play a critical role in outcomes following acute intracerebral hemorrhage. Dr. Ziai reviews key findings from ATACH-2 and INTERACT trials, the physiologic mechanisms that may link variability to hematoma expansion and neurologic deterioration and why the timing of variability within the first 8 to 12 hours appears especially important. They also examine the unresolved question of causation versus association, implications for antihypertensive management in the ICU and how emerging trials focused on variability may shape future practice. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

In this episode, Franco E. Vigna, MD, MPH, FAAOS, minimally invasive spine surgeon specializing in disc replacement, decompression, and motion preservation, shares his journey into spine surgery and the innovations shaping care today. He discusses biologics, reimbursement pressures, practice growth, and how nutrition informed recovery and regenerative strategies are improving outcomes for spine patients.

In this episode, Franco E. Vigna, MD, MPH, FAAOS, minimally invasive spine surgeon specializing in disc replacement, decompression, and motion preservation, shares his journey into spine surgery and the innovations shaping care today. He discusses biologics, reimbursement pressures, practice growth, and how nutrition informed recovery and regenerative strategies are improving outcomes for spine patients.

The Draft Room goes deep into the most overlooked — and most fun — position group in the 2026 NFL Draft: special teams. Ryan breaks down every kicker, punter, long snapper, and returner worth knowing, using his custom-built PFF database merged with the consensus big board to find the prospects others are missing.

The Draft Room goes deep into the most overlooked — and most fun — position group in the 2026 NFL Draft: special teams. Ryan breaks down every kicker, punter, long snapper, and returner worth knowing, using his custom-built PFF database merged with the consensus big board to find the prospects others are missing.

2/15/2026The Healthy Matters PodcastS05_E09 - Healthcare on Wheels!  We're Talkin' Mobile HealthWith Special Guest: Sheyanga Beecher, CNP, MSN, HMP There are many barriers to healthcare within our communities, and for a lot of people, access itself remains the greatest challenge.  Finding the time or reliable transportation to reach a clinic or hospital can prevent patients from receiving essential treatments, often allowing simpler issues to grow into far more serious conditions.  Thankfully, mobile healthcare is reshaping the way care reaches patients - meeting people where they are and changing healthcare outcomes for the better, for all of us.  But what do these programs actually entail?  What services do they offer?  And what does it take to deliver quality care on the move?On Episode 9 of our show, we'll be joined by Sheyanga Beecher (CNP, MSN, MPH), the Director of Hennepin Healthcare's mobile health program.  We'll go over the origins of mobile health, the real-world impact it's having on our communities, and why these programs extend far beyond the people they directly serve.  It's an inspired conversation on an essential piece of the healthcare puzzle.  We hope you'll join us!Got healthcare questions or ideas for future shows?Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

The following players are discussed:1. Ethan Holliday (SS, Col) - Advanced bat, plus hit tool, developing power, solid athlete2. Kade Anderson (LHP, Sea) - Advanced command, polished pitch mix, competitive edge; mid‑rotation with strikeout upside.3. Tatsuya Imai (RHP, Hou) - Undersized right-handed hitter with a lower three-quarters delivery. 97 to 99 MPH fastball that flattens out due to his arm swing. Plus slider.4. Liam Doyle (LHP, STL) - Swing-and-miss lefty with a deceptive splitter. Could be a high-strikeout SP2 if he stays healthy.5. Kazuma Okamoto (3B, Tor) - Older prospect who demonstrated plus power and a feel to hit in Japan.6. JoJo Parker (SS, Tor) - Loud tools, clean health, and trending trajectory; potential middle-of-the-order bat.7. Ike Irish (C, Bal) - Advanced hit tool, emerging power, and catcher eligibility. Impact upside with multi-category juice.8. Eli Willits (SS, Was) - Speed/OBP shortstop, needs power to unlock fantasy value.9. Aiva Arquette (SS, Mia) - Strong-bodied infielder with power upside and defensive versatility10. Seth Hernandez (RHP, Pit) - 100 MPH fastball and starter traits. Long runway, but top-30 SP ceiling if it clicks.11. Kyson Witherspoon (RHP, Bos) - Premium pitch traits, no pro debut yet.12. Wehiwa Aloy (SS, Bal) - 2025 Golden Spikes winner with power, athleticism, and SEC pedigree. Could be a fantasy shortstop with pop.13. Marek Houston (SS, Min) - High-floor bat with zone control and defensive value.14. Dax Kilby (SS, NYY) - Strong debut with more speed than originally projected; power continues to be a question mark15. Steele Hall (SS, Cin) - 80-speed and emerging power. Contact risk is real, but the tools are loud and fantasy-relevant.16. Gavin Fien (SS, Was) - Advanced bat speed, strong plate discipline, above-average power, versatile defender.17. Gavin Kilen (SS, SF) - High-contact lefty bat, 15+ HR upside, mature plate discipline18. Billy Carlson (SS, CHW) - Bat-to-ball skills and defensive value. Power projection remains limited, but everyday role possible.19. Slater De Brun (OF, TB) - A diminutive, toolsy outfielder with a great-looking swing.20. Jamie Arnold (LHP, ATH) - He has a plus fastball-slider combination but his lower three-quarters delivery might work best in the bullpen.

Hot flashes aren't the whole story. Perimenopause and menopause can impact your gut, hormones, and chronic illness symptoms - you're not imagining it. Listen to this episode of The Gut Show as we talk with Casey Farlow about what menopause is, how to get support, and more!   In this episode, we cover: Perimenopause and menopause [3:20] Introducing our guest [4:40] What is menopause? [6:01] Changes to gut health [8:53] Other symptoms [11:14] Monitoring estrogen and progesterone [13:53] Birth control [15:41] Can you stabilize hormones? [17:54] Hormone therapy & breast cancer [20:23] Is it hopeless? [21:30] Chronic illness & things getting worse [26:35] Hormone therapy and breast cancer [30:12] Who monitors this? [32:18] Labwork [35:20] Bone density screening [38:11]   Mentioned in this episode: MASTER Method Membership FREE IBS Warrior Summit Take the quiz: What's your poop personality?   About our guest: Casey Farlow, MPH, RDN is a registered dietitian and nationally recognized perimenopause nutrition expert who helps women stop fighting their bodies and start working with them during the hormonal transition of perimenopause. As the founder of The Perimenopause Nutritionist, Casey supports women struggling with stubborn weight gain, fatigue, sleep disruption, mood changes, and food frustration through hormone-aware nutrition, blood sugar regulation, and nervous system support. Connect with Casey   Thank you to our partners: ModifyHealth is the leader in evidence-based, medically-tailored meal delivery offering Monash Certified low FODMAP, Gluten free, and Mediterranean meals - expertly crafted to help you achieve better symptom control AND improve overall health.  The best part? They make it easy by doing all prep work for you. Simply choose the meals you want, stock your fridge or freezer when meals arrive at your door, then heat and enjoy when you're ready. Delicious meals. Less stress. Complete peace of mind. Check out modifyhealth.com and save 35% off your first order plus free shipping across the US with code: THEGUTSHOW.   mBIOTA is the next generation of the elemental diet. Developed with leading gastroenterologists and food scientists, it's the first formula that's both clinically effective and genuinely easy to drink. Pure, easily absorbed nutrients are essential, but the mBIOTA difference is in the details: from their proprietary Amino Taste Modification Technology (ATMT), to their fully vegan and gluten-free ingredients, mBIOTA provides balanced daily nutrition backed by science.  The result is a game-changing medical-grade formula that helps restore GI function in patients with SIBO, IMO, IBS, Crohn's, EoE and more. Learn more at mbiota.com and save 20% off their 2 week protocol with the code GUTIVATE.   FODZYME is the world's first enzyme supplement specialized to target FODMAPs. When sprinkled on or mixed with high-FODMAP meals, FODZYME's novel patent-pending enzyme blend breaks down fructan, GOS and lactose before they can trigger bloating, gas and other digestive issues.  With FODZYME, enjoy garlic, onion, wheat, brussels sprouts, beans, dairy and more — worry free! Discover the power of FODZYME's digestive enzyme blend and eat the foods you love and miss. Visit fodzyme.com and save 20% off your first order with code THEGUTSHOW. One use per customer.   Connect with Erin Judge, RD:  Instagram TikTok Work with Erin FREE symptom tracker  

About this episode: Last month's abrupt cancellation and reinstatement of $2 billion in grants is just the most recent ordeal in SAMHSA's long year of funding cuts and administrative upheaval. In this episode: Dr. Yngvild Olsen, formerly the director of the Center for Substance Abuse Treatment at SAMHSA, chronicles the challenges facing the agency and their possible implications for efforts to reduce opioid overdose deaths and improve mental health outcomes. Guests: Dr. Yngvild Olsen, MPH, is a nationally recognized leader in addiction medicine, public health policy, and clinical care integration. She currently serves as a national advisor with Manatt Health. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: 24 hours of chaos as mental health grants are slashed then restored—NPR SAMHSA Strategic Priorities—SAMHSA Progress on overdose deaths could be jeopardized by federal cuts, critics say—Stateline Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.